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Abstract:  
Photon-induced nuclear excitation (i.e. photo-excitation) can be used for 
production of nuclear isomers, which have potential applications in astrophysics, 
energy storing, and medical diagnosis and treatment. This paper presents a feasibility 
study on production of four nuclear isomers (99mTc, 103mRh and 113m, 115mIn) using 
high-intensity γ-ray source based on laser-electron Compton scattering (LCS), for use 
in the medical diagnosis and treatment. The decay properties and the medical 
applications of these nuclear isomers were reviewed. The cross-section curves, 
simulated yields and activity of product of each photo-excitation process were 
calculated. The cutoff energy of LCS γ-ray beam is optimized by adjusting the 
electron energy in order to maximize the yields as well as the activities of 
photo-excitation products. It is found that the achievable activity of above-mentioned 
isomers can exceed 10 mCi for 6-hour target irradiation at an intensity of the order of 
1013 γ/s. Such magnitude of activity satisfies the dose requirement of medical 
diagnosis. Our simulation results suggest the prospect of producing medically 
interesting isomers with photo-excitation using the state-of-art LCS γ-ray beam 
facility. 
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1. Introduction 
A radionuclide which decays by emission of γ rays and/or conversion electrons 
to reach ground state is called nuclear isomer. In most cases, nuclear isomers emit 
only gamma radiation and no beta radiation, offering the advantage of low radiation 
  
dose for patient investigations [1]. Besides offering great potential in the field of 
astrophysics and energy storing, nuclear isomers are particularly suitable for various 
applications in nuclear medicine if they can be produced with high (specific) activity 
[2]. In nuclear medicine, the present mostly used isomer is 99mTc (T1/2 = 6.01 hr). Its 
140.5 keV γ ray is ideal for single photon emission computer tomography (SPECT) 
imaging. Other isomers, such as isomers 113m, 115mIn, for example, are used in cancer 
treatments [3]. Since the high multipole order of the depopulating transitions, most of 
the decays occur via internal conversion, with subsequent cascade emission of Auger 
electrons that can be used to kill various cancer cells. There are also a few isomers, 
including 34mCl and 52mMn [4, 5], which decay by positron emission and electron 
capture and are suitable for positron emission tomography imaging. 
The radionuclide generator scheme plays a major role in production of many of 
the known isomers including 99mTc and 81mKr, which have been widely used in 
nuclear medicine [6]. In such scheme, a metastable daughter (isomer) can be 
separated from its longer-lived parent by an effective radiochemical process, such as 
simple ion exchange process. This scheme promotes the direct use of the known 
isomers with relatively short half-lives in medical applications. Currently thermal 
neutron-induced fission and charged particle reactions with protons are the main 
production routes for radionuclide generators, which rely largely on either research 
reactors or cyclotrons [7, 8]. However, most of the research reactors used for medical 
isotopes production are more than 50 years old and approaching the end of their 
useful lives [9]. Moreover, the production of required parent radionuclide is 
accompanied by yielding considerable quantities of long-lived radioactive waste. 
Cyclotrons generate a smaller amount of radioactive waste in comparison to research 
reactors, but the radionuclide production is very limited depending on installed beam 
energy. Owing to the limited number of production facilities available and the 
increasing global demand for medical isotopes, the shortage in medical isotopes, 
particularly the 99Mo/99mTc generator, has reached crisis level in the past years [9, 10]. 
With a serious shortage of medical isotopes looming, worldwide researches are 
exploring ways to make them without nuclear reactors [11, 12]. These initiatives 
include the investigation of innovative ways of production and the application of new 
radioisotopes in both imaging and therapy [13,14]. Recently, photo-production of 
99mTc with the nuclear resonance fluorescence (NRF) has been proposed by recycling 
hazardous 99Tc [15]. 
  
In this study, we present a feasibility study for producing longer-lived nuclear 
isomers for medical usage. This can be achieved by bombarding isotopic target with 
energetic γ-ray beam to induce photo-excitation process, namely (γ, γ’) reaction [16], 
hence producing nuclear isomer of interest. Laser-electron Compton scattering (LCS) 
approach is employed to produce such γ-ray beams with variable energy. We 
reviewed briefly the decay properties of selected nuclear isomers, 99mTc, 103mRh and 
113m, 115mIn and their potential applications in nuclear medicine. We then calculated (γ, 
γ’) reaction cross-section curves and simulated the activities and production yields for 
each photo-excitation process. In these simulations, we optimized the LCS γ-ray beam 
energy to maximize the isomer production. It is found that the achievable activity of 
nuclear isomers can exceed 10 mCi when each of isotopic targets is irradiated at an 
intensity of the order of 1013 γ/s for 6 hrs. Such magnitude of activity satisfies the 
dose requirement of medical imaging, indicating the prospect of producing medically 
interesting isomers with photo-excitation approach. 
 
2. Nuclear isomer via the (γ, γ’) reaction 
Longer-lived nuclear isomers are of interest for various applications in nuclear 
medicine if they can be produced with high (specific) activity. Table 1 shows a 
selection of such isomers that can be produced properly through (γ, γ’) reactions. 
Most usual production methods, e.g., via (n, γ) reactions on A − 1 target isotopes, 
result in relatively low activity since the dominant part of the production proceeds 
directly to the nuclear ground state that has a nuclear spin closer to that of the A − 1 
target isotopes. Meanwhile, (γ, n) reactions allow producing neutron-deficient 
isotopes when LCS γ-ray beams have sufficient flux density [2]. We select four 
nuclear isomers, 99mTc, 103mRh, and 113m, 115mIn, which is suitable for being produced 
through (γ, γ’) reactions considering the target availability. Particularly, 99Tc is 
independently produced in the reactors and constitutes ~0.1% of total spent fuel 
inventory [15]. However, they are not able to be produced by (γ, n) reactions due to 
those unstable A + 1 target isotopes. In the following the decay properties of these 
nuclear isomers are briefly reviewed, together with their potentially medical 
applications.  
 
Table 1. The decay properties of four nuclear isomers selected and the target isotopes required for 
  
(γ, γ’) reactions leading to these isomers. 
Isomer 
𝑇!/! 
(hr) 
Exc. energy 
(keV) 
Target 
isotope 
Nat. abundance 
or half-life 
Decay 
model 
Medical 
application 
99mTc 6.01 142.7 99Tc 2.1×105 a IT (99.9%) SPECT 
103mRh 0.94 39.8 103Rh 100% IT (100%) Radiotherapy 
113mIn 1.66 391.7 113In 4.3% IT (100%) 
SPECT; 
Radiotherapy 
115mIn 4.49 336.2 115In 95.7% IT (95%) 
SPECT; 
Radiotherapy 
 
2.1 99mTc 
99mTc (T1/2 = 6.01 hr) has been widely used for SPECT imaging. With a 
relatively short half-life and the quasi-absence of beta particles, the radiation dose to 
the patient is low. A patient can be injected with small amount of 99mTc and within 24 
hours almost 94% of the injected radionuclide would have decayed and left the body. 
99mTc can be chemically bound to small molecule ligands and proteins, which are 
concentrated in specific organ tissues after injection into the body, such as 
99mTc-HMPAO, 99mTc-ECD and 99mTc-DTPA [17]. 
2.2 103mRh 
103mRh (T1/2 = 56.1 min) is a key example of an Auger-emitting candidate. It 
decays via isomeric transition to stable 103Rh, and gives rise to emission of 
low-energy Auger electrons [18]. The 40 keV isometric decay energy is totally 
converted in the electronic shells for the stable 103Rh with no measurable γ rays and 
results in a “shower” of low-energy electrons and X rays [19]. Due to its attractive 
decay and transition properties, 103mRh is expected to exhibit high cytotoxicity and is 
an isotope of interest for radioimmunotherapy and targeted therapy. 
2.3 113mIn 
113mIn (T1/2 = 99.5 min) emits a monochromatic photon spectrum with an energy 
of 391.7 keV. The γ-emitting isomer 113mIn can be incorporated as the radioactive 
label for a series of compounds with which the brain, kidney, lungs, liver-spleen, and 
blood pools can be imaged [20]. 113mIn is also an Auger-electron emitter used for 
targeted therapy [21]. The advantage of using such isomer lies in the increased patient 
doses which are permitted within the framework of radiation safety. 
2.4 115mIn 
115mIn (T1/2 = 4.49 hr) is considered to be very potential for molecule labeling 
purposes in order to obtain suitable preparation for nuclear biology and medical 
  
applications. It decays by isomeric transition emitting γ-ray of 336 keV (~95%) and 
by β- decay emitting electrons of 0.86 MeV (~5%). Although the electron emission 
has insignificant contribution to radiation dose, it is strong enough to kill cancer cells 
so that it can be used for cancer therapy [22]. Radioisotope 115mIn is comparable to the 
most popular medical diagnostic radioisotope 99mTc but with a simpler chemical 
property as it has only one prominent oxidation state in aqueous solution [23]. 
 
3. Simulation results 
In this section, we first present the simulation of LCS γ-ray beam generation and 
the modelling of photo-excitation cross sections for four isomers shown in Table 1. 
We then discuss the isomer production as a function of irradiation time, γ-ray beam 
energy and target geometry. In the following simulations, the LCS γ-ray beam flux is 
fixed to 1013 γ/s, which is obtained at the interaction point (IP) occurring the LCS 
process; the target used for irradiation has a radius of 2 mm and a thickness of 5 cm 
by default. 
3.1 LCS γ-ray beam generation 
To induce efficiently the photo-excitation process, a high-brightness γ-ray beam 
is required, such as Bremsstrahlung beam [24] and LCS γ-ray beam [25]. The LCS 
γ-ray beam is produced by incoherent Compton back-scattering of laser light from 
brilliant high-energy electron bunches, in which the laser photons take substantial 
energy from electrons and then boost successfully into the higher X or γ-ray beam 
energy region. The energy 𝐸!  of the LCS γ-ray beam can be derived from the 
conservation of energy and momentum and can be expressed as: 𝐸! = !! !!!cos!!!!!cos!!!!/!![!!!"#(!!!!)],                   (1) 
where 𝐸! and 𝐸! are the energies of incident electron and laser photon, respectively, 𝛽 = 1− 𝛾!! is the electron velocity in terms of speed of light, 𝛾 is the Lorentz 
factor of the electron beam (e-beam), and 𝜃! and 𝜃 are the laser incident angle and 
the scattering angle with respect to the direction of the e-beam, respectively. 
Considering the head-on collision geometry, the energy 𝐸! can be simplified by [26] 𝐸! = !!!!!!!!!!!!!!!!!/!!.                         (2) 
It is shown that the cutoff energy of the scattered photons is proportional to the square 
of the energy 𝐸! in the linear LCS regime. In order to produce a high-energy LCS 
  
γ-ray beam, an energetic e-beam should be employed and the scattering angle  𝜃 ~1/𝛾 should be very small. There are a few of LCS facilities with which very 
brilliant, intense γ-ray beam can be produced. The Extreme Light Infrastructure - 
Nuclear Physics (ELI-NP) will construct a γ-ray beam system called variable-energy 
gamma ray system that will be able to provide γ-ray beam with energies up to 19.5 
MeV and spectral photon density of around 104 s-1 eV-1, which is very suitable for 
exploring different fields in photonuclear physics, such as NRF, photonuclear 
reactions, and studies of photo-excitations [27]. 
Combining with the Geant4 toolkit, a 4D (three-dimensional time and frequency 
domain) Monte Carlo laser-Compton scattering simulation (MCLCSS) code [28] is 
used to model the MeV-Class γ ray production and the following transportation. In the 
simulations we used a circularly polarized laser with a wavelength of 515 nm and 
wavelength bandwidth of 0.05%, scattering on a relativistic e-beam with an energy 
spread of 0.04% at a laser incident angle of 𝜃!=172.5o. We then diagnosed the γ 
beam characteristics when the LCS γ-ray beam arrive at the surface of the irradiation 
target. Figure 1(a) shows the simulated spectral and spatial distributions of LCS γ-ray 
beam, which are required for the following calculation of the activity of isomers. The 
spectrum has a sharp edge on high-energy cutoff which is determined by the 
bandwidths of incident electron and laser photon beams according to Eq. (2). We see 
that the scattered photons with high energies are concentrated around the center 
(𝜃 = 0), while the low-energy photons are distributed away from the center. Such a 
relation, in principle, allows one to obtain readily a quasi-monoenergetic LCS γ-ray 
beam by a simple geometrical collimation technique. 
 
Fig. 1 (a) The simulated γ-ray beam spectral distributions for different 𝐸!, and (b) spatial pattern 
for fixed 𝐸! = 550 MeV. The diagnosed plane is the surface of irradiation target with a radius of 
2 mm, which is located 1.5 m downstream of the IP. 
  
 
3.2 Photo-excitation cross section 
Since scarce data is currently available for reactions induced on excited states, 
cross sections for excitation of nuclear isomers in (γ, γ’) reactions, 𝜎 𝐸! , have been 
calculated with TALYS. TALYS is a software package for the simulation of nuclear 
reactions, which provides a complete description of all reaction channels and 
observables, and many state-of-the-art nuclear models covering all the main reaction 
mechanisms encountered in light particles induced nuclear reactions are included [29]. 
TALYS is designed to calculate the total and partial cross sections, the residual and 
isomer production cross section, the discrete and continuum γ-ray production cross 
sections, etc. For the (γ, γ’) reactions on four target nuclei, the calculations of the 
cross sections are performed with TALYS 1.6, which generate the results illustrated in 
Fig. 2. The nuclear structure ingredients used for the TALYS computations are 
explicitly presented in [30]. It can be inferred from Fig. 2 that the peak values of 𝜎 𝐸!  have magnitude of the order of mb. As the γ-ray energy increases, the 
production cross sections decrease rapidly. Specifically, the 103mRh has the highest 
production cross section, followed by the 113m,115mIn isomers. Similar to the beam 
parameters, the curves of 𝜎 𝐸!  are also necessary for the prediction of the activity 
of isomers, as discussed later. 
 
Fig. 2 Isomer production cross-section via (γ, γ’) reaction on the target isotopes listed in Table 1. 
 
3.3 Production of medically interesting isomers 
Considering an isotopic target cylindrically irradiated by the LCS γ-ray beam, 
the production rate P of isomer of interest induced by photo-excitation process can be 
expressed as [31]: 
  
𝑃 = ! !!!(!!) 𝜌𝐼(𝐸, 𝑟) 1− exp −𝜇(𝐸!) ∙ 𝐿 𝑑𝐸𝑑𝑟!!!!"#!!! .           (3) 
Here, 𝐸!! is the threshold energy of photo-excitation reaction, 𝐸!"# is the cutoff 
energy of incident photons, R and L are the radius and length of the isotopic target 𝐼(𝐸! , 𝑟) is the flux density of γ-ray beam irradiating the front surface of the target, 
and 𝜌 is number density of the target nuclei, and 𝜇(𝐸!) is the linear attenuation 
coefficient. Although the isomer is formed at the production rate P, itself still decays 
at the rate 𝜆𝑁! 𝑡 , and hence the net production rate is given by: !!! !!" = 𝑃 − 𝜆𝑁! 𝑡 ,                        (4) 
where 𝜆 = ln2/𝜏 is the decay constant of the isomer of interest with a half-life of 𝜏. 
By solving Eq. (2) and substituting the initial conditions, one could obtain the isomer 
activity as a function of irradiation time 𝑡!"": 𝐴! = 𝑃 1− 𝑒!!!!"" .                       (5) 
One can see that the isomer activity increases with irradiation time. After a few 
of half-life irradiation interval, the isomer activity reaches saturation value. When the 
irradiation stops, it then decays exponentially following 𝐴!(𝑡) = 𝐴!𝑒!!". In order to 
evaluate the production of isomer of interest, the amount of isomer decayed within a 
certain time interval can be obtained with: 𝑆 = 𝐴!(𝑡)!! 𝑑𝑡 = !! 1− 𝑒!!!!"" 1− 𝑒!!"                  (6) 
In this study, we used a data-based Monto Carlo simulation program [31] to 
calculate the production rate P and then to obtain the activity of medically interesting 
isomers. The spectral and spatial patterns of the γ-ray beam and the photo-excitation 
cross sections are chosen as input data, which also includes the attenuation coefficient 
of γ-photons inside target [32]. Figure 3 shows the activity of selected four isomers as 
a function of 𝑡!"". The isomer activity increases notably with irradiation time and 
then reaches a saturation value after more than 5 times the half-life irradiation interval. 
Furthermore, the isomer activity is closed related to the convolution between the γ-ray 
beam spectrum (see Fig. 1) and the production cross-section (see Fig. 2). It is seen 
that the achievable activity can exceed 10 mCi when the target is irradiated for 6 
hours. 
  
 
Fig. 3 Isomer activity as a function of irradiation time. The LCS γ-ray beam energy used for 
calculation is 9.5 MeV.  
 
Considering that the photo-excitation cross section is fixed for production of 
specific isomer, one may optimize the isomer activity by changing the energy 
spectrum of incident γ-ray beam. Figure 4 shows the isomer activity as a function of 
the cutoff energy of LCS γ-ray beam. It is found that for the given target dimension, 
the LCS γ-ray beam with a cutoff energy of 9.1 MeV could result in peak activity for 
99mTc. The isomers 103mRh and 113m, 115mIn have different situations. Their peak 
activities occur at the cutoff energy of ~9.5 MeV. These results show that the 
matching the LCS γ-ray beam spectrum with a peaked 𝜎 𝐸!  by using an 
appropriate γ-ray beam may provide an effective approach to producing a maximum 
activity. 
 
Fig. 4 Achievable activity as a function of LCS γ-ray beam energy with 6-hour irradiation 
 
In order to realize a better understanding on the photo-excitation process induced 
by high-intensity LCS γ-ray beam, we performed Geant4 simulations [28] and 
  
diagnosed the spatial pattern of the product isomer, such as 99mTc, under the condition 
of optimized beam energy. It is seen in Fig. 5 that the intensity of 99mTc drops along 
both radial and longitudinal directions and its peak intensity is found in the center of 
the target isotope. This effect is correlated well with the spatial pattern of the incident 
γ-ray beam, and is independent on the shape of the 𝜎 𝐸! . Since the low-energy 
photons are distributed away from the center of the target isotope and have relatively 
weak penetrability, the intensity of 99mTc shows a cone-shaped distribution in the X-Z 
plane. One can see that spatial pattern could provide the knowledge to choose 
approximate target dimension. In this case, a 99Tc target with less than 1.0 mm radius 
may match the irradiation requirement. 
 
Fig. 5 Projective distributions of production position of 99mTc in the X-Y plane and X-Z plane. 
The propagation of the incident γ-ray beam is along the Z-axis direction. 
 
Figure 6 shows the dependence of isomer activity on target thickness. For 99mTc, 
103mRh and 113m,115mIn isomers, the achievable activity increases with the increasing 
target thickness. However, when the target is thicker than 5 cm, the increase trend 
becomes slower due to the significant attenuation of the incident γ-ray beam; 
particularly, 99mTc and 103mRh isomers have a saturation activity. It has been shown 
that the specific activity decreases with the target thickness increased [13]. As a result, 
one needs to compromise with the target thickness in order to produce isomers of 
interest with sufficiently high activity as well as specific activity. 
  
.  
Fig. 6 Achievable activity of medically interesting isomers as a function of the target thickness. 
The calculations were performed with optimized γ-ray beam energy. The isotopic target has a 
radius of 2 mm and the irradiation time is 6 hours. 
 
4 Discussion 
In order to summarize our results, we present in Table 2 the optimized beam 
energies, 𝐸!,!"#, with respect to the energy 𝐸!,!"#$, leading to the peak value of the 
(γ, γ’) cross section 𝜎!"#$. It suggests that the value of 𝐸!,!"# should be slightly 
higher than the 𝐸!,!"#$. Similar phenomenon has also been observed in medical 
isotope production via (γ, n) reactions [13]. Table 2 also shows the estimates of the 
achievable activities for four isomers selected. It is found that their achievable 
activities exceed 10 mCi when each of isotopic targets is irradiated at an intensity of 
the order of 1013 γ/s for 6 hrs. Generally, mCi levels of radioactivity are adequate for 
SPECT imaging, whereas several hundreds of mCi of activity are often required for 
therapeutic applications [20]. As a result, the proposed approach, together with an 
intense LCS γ-ray beam, provides unprecedented opportunities for production of 
sufficient amounts of the isomers for medical imaging.  
 
Table 2 A brief summary of medically interesting isomers that can be produced with intense LCS 
γ-ray beam. To calculate the isomer activity, each of isotopic targets is irradiated at an intensity of 
the order of 1013 γ/s for 6 hrs. 
Isomer 
𝜎!"#$ 
(mb) 
𝐸!,!"#$ 
(MeV) 
𝐸!,!"# 
(MeV) 
𝜇(𝐸!,!"#) 
(cm-1) 
𝐴 
(mCi) 
Amount within 6-hr 
(Ci) 
99mTc 2.4 8.9 9.1 0.43 13.36 208.27 
103mRh 12.5 9.3 9.5 0.43 137.29 662.23 
113mIn 2.9 9.6 9.8 0.26 21.07 166.82 
  
115mIn 3.6 9.2 9.5 0.25 17.13                                                                                                                                                                             241.26 
 
5 Conclusion 
The 99mTc, 103mRh, and 113m, 115mIn isomers have suitable decay properties and 
hence can be used in various medical applications. We have shown that the 
production, through photo-excitation process, of these four isomers is possible for 
optimized γ-ray beam energy and target geometry. The cross-section curves, 
simulated yields and activities of production of each photo-excitation process were 
calculated. Optimal cutoff energy of LCS γ-ray beam are found to produce four 
medically interesting isomers with maximal activity. When isotopic target experience 
6-hour irradiation at an intensity of the order of 1013 γ/s, the 99mTc, and 113m, 115mIn 
isomers can be produced with activity of 10 mCi, and the 103mRh isomer with activity 
of 100 mCi. We conclude that the proposed photo-excitation approach, combined 
with the state-of-art LCS γ-ray beam facility, is suitable for production of 99mTc, 
103mRh, and 113m, 115mIn in sufficient quantities for medicine usage. 
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